202 related articles for article (PubMed ID: 32370226)
1. Long-Term Treatment Outcome of Progressive
Fukushima K; Kitada S; Abe Y; Yamamoto Y; Matsuki T; Kagawa H; Oshitani Y; Tsujino K; Yoshimura K; Miki M; Miki K; Kida H
J Clin Med; 2020 May; 9(5):. PubMed ID: 32370226
[TBL] [Abstract][Full Text] [Related]
2. Treatment Outcomes of Cavitary Nodular Bronchiectatic-Type Mycobacterium avium Complex Pulmonary Disease.
Chae G; Park YE; Chong YP; Lee HJ; Shim TS; Jo KW
Antimicrob Agents Chemother; 2022 Sep; 66(9):e0226121. PubMed ID: 35950842
[TBL] [Abstract][Full Text] [Related]
3. Comparison of Treatment Outcomes of Cavitary Mycobacterium avium Complex Pulmonary Disease with Streptomycin or Amikacin Use.
Kim SM; Chong YP; Lee HJ; Shim TS; Jo KW
Microbiol Spectr; 2023 Jun; 11(3):e0474122. PubMed ID: 37022189
[TBL] [Abstract][Full Text] [Related]
4. Treatment and outcome of non-tuberculous mycobacterial pulmonary disease in a predominantly fibro-cavitary disease cohort.
Zweijpfenning S; Kops S; Magis-Escurra C; Boeree MJ; van Ingen J; Hoefsloot W
Respir Med; 2017 Oct; 131():220-224. PubMed ID: 28947034
[TBL] [Abstract][Full Text] [Related]
5. Mycobacterium avium complex pulmonary disease: management options in HIV-negative patients.
Ramirez J; Mason C; Ali J; Lopez FA
J La State Med Soc; 2008; 160(5):248-54; quiz 254, 293. PubMed ID: 19048978
[TBL] [Abstract][Full Text] [Related]
6. Long-Term Prognosis and Antimycobacterial Glycolipid Antibody as Biomarker in Mycobacterium avium-intracellulare Complex Pulmonary Disease.
Maekura R; Miki K; Tateishi Y; Matsumoto S; Kitada S; Miki M; Kida H
Microbiol Spectr; 2022 Jun; 10(3):e0053022. PubMed ID: 35467367
[TBL] [Abstract][Full Text] [Related]
7. The Association Between Sputum Culture Conversion and Mortality in Cavitary Mycobacterium avium Complex Pulmonary Disease.
Lee JK; Kim S; Chong YP; Lee HJ; Shim TS; Jo KW
Chest; 2024 Mar; ():. PubMed ID: 38508335
[TBL] [Abstract][Full Text] [Related]
8. Factors related to response to intermittent treatment of Mycobacterium avium complex lung disease.
Lam PK; Griffith DE; Aksamit TR; Ruoss SJ; Garay SM; Daley CL; Catanzaro A
Am J Respir Crit Care Med; 2006 Jun; 173(11):1283-9. PubMed ID: 16514112
[TBL] [Abstract][Full Text] [Related]
9. [Non-tuberculous mycobacteriosis. What has been coming out].
Kajiki A
Kekkaku; 2011 Feb; 86(2):113-25. PubMed ID: 21404655
[TBL] [Abstract][Full Text] [Related]
10. Clinical characteristics and treatment outcomes of patients with macrolide-resistant Mycobacterium avium complex pulmonary disease: a systematic review and meta-analysis.
Park Y; Lee EH; Jung I; Park G; Kang YA
Respir Res; 2019 Dec; 20(1):286. PubMed ID: 31852452
[TBL] [Abstract][Full Text] [Related]
11. Long-term good outcome of the fibrocavitary form of pulmonary Mycobacterium avium complex disease with concomitant abatacept monotherapy in a patient with rheumatoid arthritis.
Banno S; Yamaguchi E; Iwagaitsu S; Nobata H; Yamaguchi M; Sugiyama H; Kinashi H; Katsuno T; Kubo A; Ito S; Ito Y
Mod Rheumatol Case Rep; 2022 Jan; 6(1):1-5. PubMed ID: 34637523
[TBL] [Abstract][Full Text] [Related]
12. Multiple Cavitary Pulmonary Nodules Caused by Mycobacterium intracellulare.
Yoo SH; Kim SR; Choi JY; Choi JW; Ko YM; Jang SH; Park JK; Sung YG; Park YJ; Oh SY; Bahk SY; Lee JH; Kim MS
Korean J Fam Med; 2016 Jul; 37(4):248-52. PubMed ID: 27468344
[TBL] [Abstract][Full Text] [Related]
13. The natural history of non-cavitary nodular bronchiectatic Mycobacterium avium complex lung disease.
Kwon BS; Lee JH; Koh Y; Kim WS; Song JW; Oh YM; Lee SD; Lee SW; Lee JS; Lim CM; Choi CM; Huh JW; Hong SB; Shim TS; Jo KW
Respir Med; 2019 Apr; 150():45-50. PubMed ID: 30961950
[TBL] [Abstract][Full Text] [Related]
14. Multicentre, open label, randomised controlled trial comparing intermittent versus daily treatment for non-cavitary nodular/bronchiectatic
Nakagawa T; Hashimoto H; Yagi M; Kogure Y; Sekimizu M; Saito AM; Ogawa K; Inoue Y
BMJ Open Respir Res; 2019; 6(1):e000434. PubMed ID: 31258920
[TBL] [Abstract][Full Text] [Related]
15. Treatment of
Kwon YS; Koh WJ; Daley CL
Tuberc Respir Dis (Seoul); 2019 Jan; 82(1):15-26. PubMed ID: 30574687
[TBL] [Abstract][Full Text] [Related]
16. [Strategies for Mycobacterium avium complex infection control in Japan: how do they improve the present situation?].
Ogawa K; Sano C
Kekkaku; 2013 Mar; 88(3):355-71. PubMed ID: 23672176
[TBL] [Abstract][Full Text] [Related]
17. Retrospective study of the predictors of mortality and radiographic deterioration in 782 patients with nodular/bronchiectatic Mycobacterium avium complex lung disease.
Gochi M; Takayanagi N; Kanauchi T; Ishiguro T; Yanagisawa T; Sugita Y
BMJ Open; 2015 Aug; 5(8):e008058. PubMed ID: 26246077
[TBL] [Abstract][Full Text] [Related]
18. Factors that affect sputum conversion and treatment outcome in patients with Mycobacterium avium-intracellulare complex pulmonary disease.
Ye JJ; Wu TS; Chiang PC; Lee MH
J Microbiol Immunol Infect; 2007 Aug; 40(4):342-8. PubMed ID: 17712469
[TBL] [Abstract][Full Text] [Related]
19. Treatment of Mycobacterium avium Complex (MAC).
Griffith DE
Semin Respir Crit Care Med; 2018 Jun; 39(3):351-361. PubMed ID: 30071550
[No Abstract] [Full Text] [Related]
20. Long-term natural history of non-cavitary nodular bronchiectatic nontuberculous mycobacterial pulmonary disease.
Moon SM; Jhun BW; Baek SY; Kim S; Jeon K; Ko RE; Shin SH; Lee H; Kwon OJ; Huh HJ; Ki CS; Lee NY; Chung MJ; Lee KS; Shin SJ; Daley CL; Koh WJ
Respir Med; 2019 May; 151():1-7. PubMed ID: 31047103
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
